HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anouk M Kesselring Selected Research

1- O- (12- (2- naphthyl)dodec- 11- enyl)- 2- O- decanoyl- sn- glycerol- 3- phosphocholine

8/2009Risk factors for treatment-limiting toxicities in patients starting nevirapine-containing antiretroviral therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Anouk M Kesselring Research Topics

Disease

2Hypersensitivity (Allergy)
08/2009 - 03/2008
1Acquired Immunodeficiency Syndrome (AIDS)
01/2010
1Viremia
08/2009
1Exanthema (Rash)
03/2008

Drug/Important Bio-Agent (IBA)

11- O- (12- (2- naphthyl)dodec- 11- enyl)- 2- O- decanoyl- sn- glycerol- 3- phosphocholineIBA
08/2009
1Nevirapine (Viramune)FDA Link
03/2008

Therapy/Procedure

1Highly Active Antiretroviral Therapy (HAART)
01/2010
1Therapeutics
03/2008